WASHINGTON — PCMA president and CEO JC Scott issued the following statement on the 2020 presidential election: “The Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs) congratulates the President-elect and looks forward to working with the new Administration on lowering prescription drug costs for all Americans. “We appreciate the stated focus of the
WASHINGTON — Pharmaceutical Care Management Association president and CEO JC Scott issued the following statement on today’s hearing in the House Committee on Oversight and Reform on pricing practices for prescription drugs: “We appreciate the House Oversight Committee keeping a spotlight on drug manufacturers’ pricing practices. While drug manufacturers are solely responsible for setting and
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the reported “counteroffer” by the pharma lobby to the Administration: “While we remain deeply engaged in seeking solutions to lower drug prices and are as eager as anyone to see more progress, as reported, the ‘counteroffer’ that has
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of the next series of ads as part of the TV and digital advertising campaign on the Administration’s plans to revive the so-called rebate rule. View the new TV ad. “President Trump made the right decision last year to protect America’s seniors by withdrawing
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued on Friday the following statement applauding the Maryland legislature and Governor Larry Hogan for enacting first-of-its-kind legislation, HB 978/SB 915, to increase transparency in the prescription drug supply chain. The legislation, sponsored by Delegate Ariana Kelly and Senator Benjamin Kramer, will give Maryland policymakers and the
WASHINGTON — On Thursday, members of the prescription drug supply and payment chain, including pharmacy benefit managers (PBMs), pharmaceutical manufacturers, pharmacies, including specialty and managed care pharmacies, and health plans, sent a letter to Vice President Mike Pence and congressional leaders affirming the safety and resiliency of the drug supply chain, and calling for public-private
WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) filed its brief with the U.S. Supreme Court in the case of Rutledge versus PCMA, arguing that a misguided Arkansas law creates inefficiencies in employer-sponsored health plans and threatens access to prescription drugs. The brief comes in advance of anticipated oral arguments next month. Unique state
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both
WASHINGTON — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty pharmacies. “As prescription drug prices
WASHINGTON — As prescription drug spending is poised to reach as much as $5 trillion during the next decade, new data find that pharmacy benefit managers’ (PBMs’) proven cost savings and patient care management tools should reduce prescription drug costs for health plan sponsors and consumers by an average of 20%, or more than $1
WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) announced that Jon Roberts, executive vice president and chief operating officer of CVS Health becomes chairman of PCMA’s board of directors. “I’m honored to serve as chairman of the PCMA board of directors, supporting the association’s efforts to change the dialogue around prescription drugs with a
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting real-time benefit tools to give prescribers and patients at the point of prescribing information on
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Americans. There is still a problem of affordability for consumers that
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the addition of IngenioRx as its newest member company. IngenioRx provides pharmacy benefit management services to payers, including affiliates of Anthem, Inc. (ANTM), and is focused on bringing new clarity to the complicated world of pharmacy so members get the benefits they need in a way that’s